|

Anti-PD-1/PD-L1 treatment Clinical Trials

1 actively recruiting trial

Pipeline

Phase 2: 1

Top Sponsors

  • Vestre Viken Hospital Trust1

Indications

  • NSCLC, Stage III1
  • NSCLC Stage IV1
  • Oncology1
  • Lung Cancer1
  • Cancer1

Other1 trial

Efficacy and Safety of Anti-PD-1/PD-L1 Treatment +/- UV1 Vaccination in Patients With Non-small Cell Lung Cancer
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.